mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-11 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-11 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-10 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-09 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-08 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-06 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |